环境PM2.5暴露:与血液透析患者血镉水平相关的一个被忽视的因素

IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics
Therapeutics and Clinical Risk Management Pub Date : 2025-01-03 eCollection Date: 2025-01-01 DOI:10.2147/TCRM.S496491
Ching-Wei Hsu, Ming-Jen Chan, Cheng-Hao Weng, Tsung-Yu Tsai, Tzung-Hai Yen, Wen-Hung Huang
{"title":"环境PM2.5暴露:与血液透析患者血镉水平相关的一个被忽视的因素","authors":"Ching-Wei Hsu, Ming-Jen Chan, Cheng-Hao Weng, Tsung-Yu Tsai, Tzung-Hai Yen, Wen-Hung Huang","doi":"10.2147/TCRM.S496491","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The negative impacts of particulate matter with an aerodynamic diameter of 2.5 μm or less (PM<sub>2.5</sub>) are well known. Patients undergoing maintenance hemodialysis (HD) have significantly higher blood cadmium levels (BCLs) than healthy individuals. As elemental cadmium can be found in the PM<sub>2.5</sub> particle fraction, we conducted this study to assess the effect of environmental PM<sub>2.5</sub> exposure and other clinical variables on BCLs in maintenance HD patients.</p><p><strong>Patient and methods: </strong> This cross-sectional study included 754 hD patients who had previously participated in a BCL study. Demographic, hematological, biochemical and dialysis-related data were collected for analysis. For each patient, the mean PM<sub>2.5</sub> concentrations in the living environment during the previous 12 and 24 months were recorded and analyzed.</p><p><strong>Results: </strong>Of all patients, the median BCL of was 0.36 µg/L (range: 0.21, 0.79 µg/L). The mean PM<sub>2.5</sub> concentration was 28.45 ± 3.57 μg/m<sup>3</sup> during the 12 months and 29.81 ± 3.47 μg/m<sup>3</sup> during the 24 months, respectively. From a multivariate linear regression analysis, log BCL was positively associated with the mean PM<sub>2.5</sub> concentration during the previous 12 and 24 months. In addition, log BCL was positively associated with the number of days with PM<sub>2.5</sub> concentrations above the standard level during the previous 12 and 24 months. Moreover, according to the tertiles of days with a daily mean PM<sub>2.5</sub> concentration above the normal limit in the previous 24 months, patients with the highest exposure days exhibited a significantly higher BCL than those in the other two patient groups.</p><p><strong>Conclusion: </strong>Chronic environmental exposure to PM<sub>2.5</sub> is significantly associated with BCLs in maintenance HD patients, and exposure to PM<sub>2.5</sub>-bound cadmium may contribute to the harmful effects on health in this population. Further studies are needed to confirm these observations and to explore the underlying mechanisms.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"1-13"},"PeriodicalIF":2.8000,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11706018/pdf/","citationCount":"0","resultStr":"{\"title\":\"Environmental PM<sub>2.5</sub> Exposure: An Ignored Factor Associated with Blood Cadmium Level in Hemodialysis Patients.\",\"authors\":\"Ching-Wei Hsu, Ming-Jen Chan, Cheng-Hao Weng, Tsung-Yu Tsai, Tzung-Hai Yen, Wen-Hung Huang\",\"doi\":\"10.2147/TCRM.S496491\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The negative impacts of particulate matter with an aerodynamic diameter of 2.5 μm or less (PM<sub>2.5</sub>) are well known. Patients undergoing maintenance hemodialysis (HD) have significantly higher blood cadmium levels (BCLs) than healthy individuals. As elemental cadmium can be found in the PM<sub>2.5</sub> particle fraction, we conducted this study to assess the effect of environmental PM<sub>2.5</sub> exposure and other clinical variables on BCLs in maintenance HD patients.</p><p><strong>Patient and methods: </strong> This cross-sectional study included 754 hD patients who had previously participated in a BCL study. Demographic, hematological, biochemical and dialysis-related data were collected for analysis. For each patient, the mean PM<sub>2.5</sub> concentrations in the living environment during the previous 12 and 24 months were recorded and analyzed.</p><p><strong>Results: </strong>Of all patients, the median BCL of was 0.36 µg/L (range: 0.21, 0.79 µg/L). The mean PM<sub>2.5</sub> concentration was 28.45 ± 3.57 μg/m<sup>3</sup> during the 12 months and 29.81 ± 3.47 μg/m<sup>3</sup> during the 24 months, respectively. From a multivariate linear regression analysis, log BCL was positively associated with the mean PM<sub>2.5</sub> concentration during the previous 12 and 24 months. In addition, log BCL was positively associated with the number of days with PM<sub>2.5</sub> concentrations above the standard level during the previous 12 and 24 months. Moreover, according to the tertiles of days with a daily mean PM<sub>2.5</sub> concentration above the normal limit in the previous 24 months, patients with the highest exposure days exhibited a significantly higher BCL than those in the other two patient groups.</p><p><strong>Conclusion: </strong>Chronic environmental exposure to PM<sub>2.5</sub> is significantly associated with BCLs in maintenance HD patients, and exposure to PM<sub>2.5</sub>-bound cadmium may contribute to the harmful effects on health in this population. Further studies are needed to confirm these observations and to explore the underlying mechanisms.</p>\",\"PeriodicalId\":22977,\"journal\":{\"name\":\"Therapeutics and Clinical Risk Management\",\"volume\":\"21 \",\"pages\":\"1-13\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-01-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11706018/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutics and Clinical Risk Management\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/TCRM.S496491\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutics and Clinical Risk Management","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/TCRM.S496491","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

背景:空气动力学直径小于等于2.5 μm的颗粒物(PM2.5)的负面影响是众所周知的。维持性血液透析(HD)患者的血镉水平(BCLs)明显高于健康人。由于PM2.5颗粒组分中含有元素镉,因此我们开展了本研究,以评估环境PM2.5暴露等临床变量对维持性HD患者bcl的影响。患者和方法:这项横断面研究包括754名hD患者,他们之前曾参加过BCL研究。收集人口学、血液学、生化和透析相关数据进行分析。记录并分析每位患者前12个月和24个月生活环境中PM2.5的平均浓度。结果:所有患者的中位BCL为0.36µg/L(范围:0.21,0.79µg/L)。12个月PM2.5平均浓度为28.45±3.57 μg/m3, 24个月平均浓度为29.81±3.47 μg/m3。通过多元线性回归分析,对数BCL与前12个月和24个月的PM2.5平均浓度呈正相关。此外,log BCL与过去12个月和24个月PM2.5浓度高于标准水平的天数呈正相关。此外,根据前24个月PM2.5日均浓度高于正常值的天数,暴露天数最高的患者BCL明显高于其他两组患者。结论:慢性环境暴露于PM2.5与维持性HD患者的bcl显著相关,暴露于PM2.5结合的镉可能对该人群的健康产生有害影响。需要进一步的研究来证实这些观察结果并探索潜在的机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Environmental PM2.5 Exposure: An Ignored Factor Associated with Blood Cadmium Level in Hemodialysis Patients.

Background: The negative impacts of particulate matter with an aerodynamic diameter of 2.5 μm or less (PM2.5) are well known. Patients undergoing maintenance hemodialysis (HD) have significantly higher blood cadmium levels (BCLs) than healthy individuals. As elemental cadmium can be found in the PM2.5 particle fraction, we conducted this study to assess the effect of environmental PM2.5 exposure and other clinical variables on BCLs in maintenance HD patients.

Patient and methods:  This cross-sectional study included 754 hD patients who had previously participated in a BCL study. Demographic, hematological, biochemical and dialysis-related data were collected for analysis. For each patient, the mean PM2.5 concentrations in the living environment during the previous 12 and 24 months were recorded and analyzed.

Results: Of all patients, the median BCL of was 0.36 µg/L (range: 0.21, 0.79 µg/L). The mean PM2.5 concentration was 28.45 ± 3.57 μg/m3 during the 12 months and 29.81 ± 3.47 μg/m3 during the 24 months, respectively. From a multivariate linear regression analysis, log BCL was positively associated with the mean PM2.5 concentration during the previous 12 and 24 months. In addition, log BCL was positively associated with the number of days with PM2.5 concentrations above the standard level during the previous 12 and 24 months. Moreover, according to the tertiles of days with a daily mean PM2.5 concentration above the normal limit in the previous 24 months, patients with the highest exposure days exhibited a significantly higher BCL than those in the other two patient groups.

Conclusion: Chronic environmental exposure to PM2.5 is significantly associated with BCLs in maintenance HD patients, and exposure to PM2.5-bound cadmium may contribute to the harmful effects on health in this population. Further studies are needed to confirm these observations and to explore the underlying mechanisms.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Therapeutics and Clinical Risk Management
Therapeutics and Clinical Risk Management HEALTH CARE SCIENCES & SERVICES-
CiteScore
5.30
自引率
3.60%
发文量
139
审稿时长
16 weeks
期刊介绍: Therapeutics and Clinical Risk Management is an international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas. The journal welcomes submissions covering original research, clinical and epidemiological studies, reviews, guidelines, expert opinion and commentary. The journal will consider case reports but only if they make a valuable and original contribution to the literature. As of 18th March 2019, Therapeutics and Clinical Risk Management will no longer consider meta-analyses for publication. The journal does not accept study protocols, animal-based or cell line-based studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信